Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
01 1PolyCarbon Industries, Inc.
02 1Enaltec Labs Private Limited
03 1Patheon Manufacturing Services LLC
01 1ETHACRYNATE SODIUM
02 1Ethacrynate Sodium
03 1ethacrynate sodium
01 1France
02 1India
03 1U.S.A
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
NDC Package Code : 65571-0026
Start Marketing Date : 2011-08-30
End Marketing Date : 2025-11-30
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 42413-0062
Start Marketing Date : 2012-03-13
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63552-145
Start Marketing Date : 1967-01-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER, FOR SOLUTION (50mg/50mL)
Marketing Category : DRUG FOR FURTHER PROCESSING
46
PharmaCompass offers a list of Ethacrynate Sodium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ethacrynate Sodium manufacturer or Ethacrynate Sodium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ethacrynate Sodium manufacturer or Ethacrynate Sodium supplier.
PharmaCompass also assists you with knowing the Ethacrynate Sodium API Price utilized in the formulation of products. Ethacrynate Sodium API Price is not always fixed or binding as the Ethacrynate Sodium Price is obtained through a variety of data sources. The Ethacrynate Sodium Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate, including repackagers and relabelers. The FDA regulates sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate supplier is an individual or a company that provides sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate active pharmaceutical ingredient (API) or sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate finished formulations upon request. The sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate suppliers may include sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate API manufacturers, exporters, distributors and traders.
click here to find a list of sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate suppliers with NDC on PharmaCompass.
We have 3 companies offering sodium;2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetate
Get in contact with the supplier of your choice:
